STTK
NASDAQ · Biotechnology
Shattuck Labs Inc
$6.26
-0.41 (-6.15%)
Open$6.52
Previous Close$6.67
Day High$6.60
Day Low$6.22
52W High$8.33
52W Low$0.71
Volume—
Avg Volume656.5K
Market Cap511.46M
P/E Ratio—
EPS$-0.64
SectorBiotechnology
Analyst Ratings
Strong Buy
14 analysts
Price Target
+685.0% upside
Current
$6.26
$6.26
Target
$49.14
$49.14
$35.75
$49.14 avg
$66.29
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 1.08M | 931.4K | 31.76M |
| Net Income | -52,370,423 | -40,829,331 | 1.18M |
| Profit Margin | -4,880.9% | -4,636.9% | 3.7% |
| EBITDA | -51,317,638 | -42,231,250 | 2.48M |
| Free Cash Flow | — | — | 903.7K |
| Rev Growth | +15.4% | +15.4% | -3.0% |
| Debt/Equity | — | — | 0.48 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $213.76 | +2.08% | 88.1 | 372.39B |
| AMGN | Amgen Inc | $330.33 | -0.13% | 23.0 | 179.23B |
| GILD | Gilead Sciences Inc | $130.28 | -0.17% | 17.4 | 160.50B |
| VRTX | Vertex Pharmaceuticals Inc | $429.32 | -1.15% | 26.4 | 114.32B |
| REGN | Regeneron Pharmaceuticals | $641.69 | +1.81% | 16.7 | 73.89B |
| ALNY | Alnylam Pharmaceuticals Inc | $293.86 | -0.15% | 66.6 | 38.43B |